Authors:
FROTSCHL R
CHICHMANOV L
KLEEBERG U
HILDEBRANDT AG
ROOTS I
BROCKMOLLER J
Citation: R. Frotschl et al., CYTOCHROME-P450 1A1 MESSENGER-RNA INDUCTION BY DRUGS AND ENVIRONMENTAL CHEMICALS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 429-429
Authors:
FROTSCHL R
CHICHMANOV L
KLEEBERG U
HILDEBRANDT AG
ROOTS I
BROCKMOLLER J
Citation: R. Frotschl et al., CYTOCHROME-P450 1A1 INDUCTION BY 17 DRUGS AND ENVIRONMENTAL CHEMICALSMEASURED BY QUANTITATIVE RT PCR, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 638-638
Authors:
BROCKMOLLER J
FROTSCHL R
KLEEBERG U
HILDEBRANDT AG
ROOTS I
Citation: J. Brockmoller et al., TRANSCRIPTIONAL ACTIVATION OF DRUG-METABOLIZING-ENZYMES BY OMEPRAZOLEIN-VIVO MEASURED BY QUANTITATIVE RT-PCR, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 64-64
Authors:
KRUSEKOPF S
KLEEBERG U
HILDEBRANDT AG
RUCKPAUL K
Citation: S. Krusekopf et al., EFFECTS OF BENZIMIDAZOLE DERIVATIVES ON CYTOCHROME-P450 1A1 EXPRESSION IN A HUMAN HEPATOMA-CELL LINE, Xenobiotica, 27(1), 1997, pp. 1-9
Authors:
FROTSCHL R
KLEEBERG U
HILDEBRANDT AG
ROOTS I
BROCKMOLLER J
Citation: R. Frotschl et al., POLYMERASE CHAIN-REACTION (PCR)-BASED CONSTRUCTION OF A COMPETITOR TARGET FOR QUANTITATIVE REVERSE-TRANSCRIPTASE PCR MEASUREMENT OF CYTOCHROME-P450 1A1 MESSENGER-RNA, Analytical biochemistry, 242(2), 1996, pp. 280-282
Authors:
DUBOIS A
VACH W
CRAMERGIRAUD U
THOMSSEN C
GLAUBITZ M
FIOLA M
AUGENER W
BARTSCH W
BERGMANN F
BIERBAUM W
KRAPP J
BONING L
BONGARTZ U
BRUNTSCH U
VONBULTZINGSLOWEN F
DIETL J
FUGER T
FULLE HH
GATZEMEIER U
GROPP C
HARTLAPP H
HERSCHLEIN HJ
HOLTKAMP W
HURST U
JANICKE F
KAUKEL E
KLEEBERG U
ENGEL E
KRAFFT W
KUHNLE H
LINDEMANN H
MARSCHNER N
MEERPOHL HG
NIEDERLE N
OSIEKA R
PLANKER M
RIESS H
SCHMIDT M
SCHMOLL HJ
SCHUNEMANN H
WEINGARTJESSE B
WEITZEL H
WESTERHAUSEN M
WINKELMANN M
Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651
Citation: O. Gefeller et al., ADJUVANT TREATMENT OF PRIMARY MALIGNANT-M ELANOMA WITH NATURAL INTERFERON-BETA - SIGNIFICANT SURVIVAL ADVANTAGE IN 96 TREATED PATIENTS COMPARED WITH 288 UNTREATED CONTROLS, Hautarzt, 45(3), 1994, pp. 191-192